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Abstract 
The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 
threatens global medical systems and economies, and rules our daily living life. Controlling 
the outbreak of SARS-CoV-2 has become one of the most important and urgent strategies 
throughout the whole world. As of October, 2020, there have not yet been any medicines or 
therapies to be effective against SARS-CoV-2. Thus, rapid and sensitive diagnostics is the most 
important measures to control the outbreak of SARS-CoV-2. Homogeneous biosensing based 
on magnetic nanoparticles (MNPs) is one of the most promising approaches for rapid and 
highly sensitive detection of biomolecules. This paper proposes an approach for rapid and 
sensitive detection of SARS-CoV-2 with functionalized MNPs via the measurement of their 
magnetic response in an ac magnetic field. Experimental results demonstrate that the proposed 
approach allows the rapid detection of mimic SARS-CoV-2 with a limit of detection of 0.084 
nM (5.9 fmole). The proposed approach has great potential for designing a low-cost and point-
of-care device for rapid and sensitive diagnostics of SARS-CoV-2. 
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1. Introduction 
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an RNA based virus 
that causes coronavirus disease 2019 (COVID-19) [1]. SARS-CoV-2 with a dimeter ranging 
from about 60 to 140 nm has spike, envelope, membrane and nucleocapsid proteins [2, 3]. 
Spike protein is the one for allowing the virus to bind to the receptor ACE2 of a host cell and 
to enter the host cell [4-8]. A patient infected with SARS-CoV-2 may suffer from severe 
pneumonia and acute respiratory distress syndrome [3, 9, 10]. Since the first infection case of 
SARS-CoV-2 reported in December, 2019 [10, 11], SARS-CoV-2 has spread across the whole 
world, which causes severe problems in medical systems, economics and other social issues. 
Till early October 2020, World Health Organization (WHO) has reported more than 35 million 
cases of infection and 1 million deaths in the world [12]. In addition to other control measures, 
e.g. social distance and hand washing, WHO has strongly recommended a large amount of 
testing not only of symptomatic persons and their contacts but also of asymptomatic contacts. 
Therefore, large amounts of tests are one of the most important measures to control the outbreak 
of SARS-CoV-2. 
 To date, polymerase chain reaction (PCR) based tests with high sensitivity and specificity 
are the gold standard for the diagnostics of SARS-CoV-2 infection [13, 14]. PCR tests include 
several complex experimental procedures, which costs at least a few hours to get the test results. 
In a PCR test, most experimental procedures require sophisticated and very expensive 
instrumentation and should be handled by experienced experts. Otherwise, there is a high 
chance for a false positive/negative result. It leads to huge efforts for medical staffs in the 
clinics, especially during the exponential increase in infection cases. In developing and 
underdeveloped countries, the situation for the diagnostics of SARS-CoV-2 with PCR is even 
worse due to the lack of equipped labs, instrumentation and experienced experts. Therefore, it 
is of extreme importance and necessity to develop new methods and/or instrumentation for 
rapid diagnostics of SARS-CoV-2 with reasonable costs. WHO highly encourages researches 
on the performance of rapid diagnostics approaches and potential diagnostic utilities. However, 
Page 3 of 21 
the development of new approaches for rapid diagnostics, in addition to PCR-based tests, is 
still a challenging research topic.  
Homogeneous biosensing based on magnetic nanoparticles (MNPs) is one of the most 
promising approaches for rapid and sensitive detection of specific biomolecules, e.g. protein, 
DNA/RNA and virus. It employs the change in the magnetization dynamics and consequent 
magnetic response of the MNPs exposed to time-varying magnetic fields [15]. The binding 
behavior of the biomolecules to functionalized MNPs, dominated by Brownian relaxation, 
increases their hydrodynamic size or forms cross-linking structures, which significantly 
changes the Brownian relaxation time of the MNPs and their dynamic magnetization in time-
varying magnetic fields [16-18]. For instance, for MNPs bound with biomolecules, the 
harmonics in magnetic particle spectroscopy (MPS) dominated by Brownian relaxation 
decrease when exposed to a sufficiently strong ac magnetic field. Especially, higher harmonics 
decrease faster than the fundamental harmonic, thus showing a decrease in the harmonic ratio 
that is independent of the MNP concentration [16, 19]. Thus, the measurement of the MNP 
magnetization and its susceptibility/spectra in ac magnetic fields can be used to detect the 
quantity of specific biomolecules. An MPS system has been demonstrated to be a low-cost, 
versatile and sensitive tool to measure MNP magnetization and dynamics for biomolecule 
detection [16, 20]. For instance, a mixing-frequency MPS system was designed to measure the 
mixing components of protein G-functionalized MNP magnetization for antibody detection 
[21]. Zhang et al. reported on the measurement of the harmonic ratio of anti-thrombin DNA 
aptamers-functionalized MNPs for the detection of thrombin [22]. Zhong et al. investigated the 
effect of binding behavior on MNP relaxation time and harmonic ratio for the detection and 
imaging of biotinylated IgG using streptavidin functionalized MNPs [16, 19]. Yang et al. 
demonstrated the feasibility of wash-free, sensitive and specific assays for the detection of 
different viruses, e.g. orchid and influenza viruses, with antibody-functionalized MNPs by 
measuring the reduction in the ac susceptibility in mixed-frequency ac magnetic fields [23-25]. 
Tian et al. reported on homogeneous detection of SARS-CoV-2 utilizing an opto-magnetic 
measurement system for the detection of the RND-dependent RNA polymerase coding 
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sequence of SARS-CoV-2 [26]. All these approaches have demonstrated that MNP-based 
homogeneous biosensing is a wash-free and mix-and-measure approach for rapid and sensitive 
detection of specific biomolecules. Therefore, it is of great interest and importance to 
investigate MNP-based biosensing for rapid and sensitive detection of SARS-CoV-2. 
In this paper, we propose the detection of SARS-CoV-2 via the measurement of the MPS 
signal of SARS-CoV-2 spike protein antibody-functionalized MNPs. For the proof-of-concept, 
SARS-CoV-2 spike protein antibody-functionalized MNPs are used as sensors to detect mimic 
SARS-CoV-2 that is 100 nm polystyrene bead conjugated with SARS-CoV-2 spike protein. A 
custom-built MPS system is used to measure the MPS signal of the functionalized MNPs. In 
addition, the ac susceptibility (ACS) spectra are measured with a rotating magnetic field (RMF) 
system for the evaluation of the Brownian relaxation time. Experiments on samples with 
different mimic virus concentrations are performed to evaluate the measurement sensitivity and 
limit of detection (LOD) of the present approach. 
2. Materials and Methods 
In this paper, functionalized MNPs dominated by Brownian relaxation are used to detect 
a mimic SARS-CoV-2. The functionalized MNPs consist of BNF-80 nanoparticles coated with 
protein A, purchased from micromod Partikeltechnologie GmbH (Rostock, Germany), and 
SARS-CoV-2 spike protein monoclonal antibodies (anti-SARS-CoV-2 spike), purchased from 
Biomol GmbH (Hamburg, Germany), as show in Fig. 1a. Due to the high binding affinity 
between protein A and the antibody Fc fragment, SARS-CoV-2 spike protein antibodies are 
easily conjugated onto the surface of protein A-coated BNF-80 nanoparticles. BNF-80 
nanoparticles with protein A have an original iron concentration of 5.5 mg/ml and molar 
particle concentration of 20 pmole/mL (20 nM). The stock BNF-80 nanoparticle sample is 
diluted to 2 nM for experiments. The mimic SARS-CoV-2 consists of streptavidin-coated 
polystyrene beads (purchased from micromod Partikeltechnologie GmbH) and biotinylated 
SARS-CoV-2 spike proteins (RBD-SD1, Avi-His Tag, from Biomol GmbH), as show in Fig. 
1b. Due to the high binding affinity between streptavidin and biotin, the biotinylated SARS-
CoV-2 spike proteins are conjugated onto the surface of streptavidin-functionalized 
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polystyrene beads. The polystyrene beads have a nominal size of 100 nm, which is similar to 
the size of SARS-CoV-2 [27].  
The functionalized MNPs and mimic SARS-CoV-2 are prepared and incubated for more 
than 12 hours prior to experiments. To make sure the conjugation between the antigen and 
antibody is finished, experiments on the measurements of ACS spectra and MPS signal are 
performed more than 1 hour after mixing the functionalized MNPs and the mimic SARS-CoV-
2. Totally, five experimental samples with different mimic virus concentrations from 0 to 3.38 
nM are prepared. Note that in this paper all the mole quantity/concentration of mimic virus is 
given by that of polystyrene beads. Table I lists all the details regarding the amounts of BNF-
80 nanoparticles, antibody, spike protein and polystyrene beads for sample preparation. Each 
sample contains the same-concentration (2 nM) of functionalized MNPs. For the functionalized 
MNPs, the quantity of the SARS-CoV-2 spike protein antibody is 4 pmole, which is – 
according to preliminary tests – a balance between the binding affinity of the functionalized 
MNPs and an increase in their hydrodynamic sizes. For control experiments, the protein A-
coated BNF-80 nanoparticles without SARS-CoV-2 spike protein antibody are used to study 
the non-specific binding between the unfunctionalized MNPs and the mimic SARS-CoV-2 as 
well as an increase in viscosity due to the presence of the mimic SARS-CoV-2. The samples 
for control experiments are prepared in the same way as that for measurements, except the 
absence of the SARS-CoV-2 spike protein antibodies. 
 
Fig. 1. (a) Schematic of functionalized MNPs, (b) schematic of mimic SARS-CoV-2, (c) Schematic of 
MPS signal with and without mimic virus. 
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Table I. Sample preparation for rapid detection of mimic SARS-CoV-2. 
 Functionalized MNPs Mimic SARS-CoV-2 Total 
volume 
SARS-CoV-2 
concentration  BNF-80 
with 
protein A 
SARS-CoV-2 
spike protein 
antibody 
Polystyrene 
beads 
Biotinylated 
spike 
protein 
S1 0.18 pmole 4 pmole 0.000 pmole 0.0 pmole 90 l 0.00 nM 
S2 0.18 pmole 4 pmole 0.076 pmole 7.6 pmole 90 l 0.84 nM 
S3 0.18 pmole 4 pmole 0.152 pmole 15.2 pmole 90 l 1.68 nM 
S4 0.18 pmole 4 pmole 0.228 pmole 22.8 pmole 90 l 2.53 nM 
S5 0.18 pmole 4 pmole 0.304 pmole 30.4 pmole 90 l 3.38 nM 
 
Exposed to a sufficiently strong ac magnetic field with excitation frequency f0, the MPS 
signal consists of not only the fundamental harmonic at frequency f0 but also higher harmonics 
at frequency i×f0. Fig. 1c shows the schematic of the MPS signal of the MNPs dominated by 
Brownian relaxation. In absence of mimic SARS-CoV-2, the functionalized MNPs can freely 
rotate, thus resulting in rich harmonic spectra. With the presence of mimic SARS-CoV-2, the 
functionalized MNPs bind with the mimic SARS-CoV-2 due to the specific binding behavior 
between antibody and antigen. This leads to an increase in effective hydrodynamic size of the 
MNPs. Consequently, the functionalized MNPs cannot freely rotate or rotate slowly in 
response to the excitation magnetic field, which causes a significant decrease in the MPS signal. 
Therefore, the quantity of mimic SARS-CoV-2 can be measured and quantified by the 
measurement of MPS signal of the functionalized MNPs. In this paper, a detection coil-based 
scanning MPS system is used to measure the MPS signal of the functionalized MNPs for rapid 
detection of mimic SARS-CoV-2 in 10 mT-excitation magnetic field in the frequency range 
from 140 Hz to 1.4 kHz [28]. The measurement time for MPS amounts to about 9 seconds, 
including 1 second for sample measurement, 1 second for blank measurement and 7 seconds 
for mechanical movement. In addition, a fluxgate sensor-based RMF system is used to measure 
the ACS spectra in a 0.5 mT-excitation magnetic field in the frequency range from 1 Hz to 3 
kHz [29]. The sample volumes for the measurements of ACS spectra and MPS are 90 L and 
70 L, respectively. 
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3. Results 
3.1 AC Susceptibility 
Figure 2 shows the measured ACS spectra of functionalized and unfunctionalized MNPs 
with different mimic virus concentrations. Fig. 2a shows the measured imaginary parts of the 
ACS spectra on the functionalized MNPs. With increasing mimic virus concentration, the 
shape of the ACS spectra gets broader and the peak frequency shifts to a lower frequency. This 
indicates an increase in the effective Brownian relaxation time B [16]. Fig. 2b shows the 
measured imaginary parts of the ACS spectra for the unfunctionalized MNPs. The shape of the 
imaginary parts shown in Fig. 2b slightly shifts to lower frequencies with increasing mimic 
virus concentration. It may be caused by non-specific binding between the mimic virus and the 
unfunctionalized MNPs, as well as an increase in the solution viscosity due to the presence of 
the mimic virus. The changes in the ACS spectra of the functionalized MNPs are much more 
significant than those of the unfunctionalized MNPs, indicating that the specific binding 
behaviors between the SARS-CoV-2 antigen and antibody dominate. 
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Fig. 2. Experimental results of ac susceptibility spectra of functionalized (a) and unfunctionalized (b) MNPs 
with different mimic virus concentration. Symbols are experimental data whereas solid lines are fitting with a 
generalized Debye model with bi-lognormal size distribution. 
 
To quantitatively investigate the dependence of the effective Brownian relaxation time B 
on the mimic virus concentration, B was estimated from the peak frequency of the ac 
susceptibility imaginary part. To precisely determine the peak frequency despite the limited 
number of data points, the imaginary parts of the ACS spectra were fitted with a generalized 
Debye model with a bimodal lognormal size distribution. The solid lines in Fig. 2 shows that 
the generalized Debye model fits the experimental data very well. Then, B was calculated via 
the peak frequency fpeak of the maximum in the fitted imaginary parts applying B = 
1/(2××fpeak). Fig. 3 shows the dependence of the effective Brownian relaxation time B on the 
mimic virus concentration of functionalized and unfunctionalized MNPs. For the 
unfunctionalized MNPs, B increases by a factor of about 1.05 (from 0.687 to 0.719 ms) 
whereas for functionalized MNPs B significantly increases by a factor of about 1.74 (from 
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0.742 to 1.292 ms). Additional control experiments on ACS spectra were also performed with 
BNF-80 nanoparticles functionalized with some other antibodies (not specific to SARS-CoV-
2 spike protein) and the mimic virus (data not shown), which also show minor changes in the 
effective Brownian relaxation time. This indicates that the specific binding between SARS-
CoV-2 antigen and antibody significantly increases the effective Brownian relaxation time B. 
Note that, for a mimic virus concentration cmv = 0 nM, B for the functionalized MNPs is greater 
than that for the unfunctionalized MNPs, which is caused by a larger hydrodynamic size of the 
functionalized MNPs due to the conjugation of SARS-CoV-2 spike protein antibodies onto the 
surface of the protein A-coated BNF-80 nanoparticles. Therefore, our experimental results 
demonstrate that the specific binding of the mimic SARS-CoV-2 onto the surface of the 
functionalized MNPs significantly increases the effective Brownian relaxation time. 
 
Fig. 3. Experimental results of effective Brownian relaxation time vs. mimic SARS-CoV-2 concentration. 
Symbols are experimental data whereas solid lines are guides to the eyes. 
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3.2 Magnetic Particle Spectroscopy 
The custom-built SMPS was used to measure the 1st and 3rd harmonics (M1 and M3) of the 
output voltage from the gradiometric detection coils on experimental samples in ac magnetic 
fields with different excitation frequencies f0, where the harmonic at frequency i×f0 is defined 
as ith harmonic Mi. Figure 4 shows the experimental results of the harmonic ratio R3rd/1st = 
M3/M1 vs. frequency curves on samples with different mimic virus concentrations cmv. Note 
that the harmonic ratio is independent of the MNP concentration, but only dependent on the 
mimic virus concentration cmv in a given-frequency ac magnetic field. Figures 4a and 4b show 
the experimental results of functionalized and unfunctionalized MNPs, respectively. Without 
SARS-CoV-2 spike protein antibody functionalization, the harmonic ratio R3rd/1st of the MNPs 
coated with protein A slightly decreases with increasing mimic virus concentration cmv, which 
might be caused by non-specific binding and viscosity changes due to the presence of the mimic 
virus. On the other hand, with SARS-CoV-2 spike protein antibody functionalization, the 
harmonic ratio R3rd/1st of the functionalized MNPs decreases significantly with an increase in 
the mimic virus concentration cmv. Moreover, the changes in the R3rd/1st decrease with 
increasing excitation frequency, which agrees well with published results [16]. By comparing 
Figs. 4a and 4b, the amounts of mimic SARS-CoV-2 can be quantified with the harmonic ratio 
R3rd/1st at each single excitation frequency. 
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Fig. 4. Experimental results of measured harmonic ratio R3rd/1st vs. excitation frequency of functionalized (a) and 
unfunctionalized (b) MNPs with different mimic virus concentration cmv. Experimental results are averaged for 
4 independent repeat measurements. Symbols are experimental results whereas solid lines are guides to the eyes. 
 
To quantitatively evaluate the changes in R3rd/1st vs. mimic SARS-CoV-2 concentration 
cmv, the absolute change R3rd/1st = R3rd/1st(cmv = 0 nM) - R3rd/1st(cmv) was calculated and 
presented in Fig. 5. Figure 5a and 5b show R3rd/1st vs. mimic SARS-CoV-2 concentration cmv 
curves of functionalized and unfunctionalized MNPs at different excitation frequencies, 
respectively. It clearly shows that the changes in R3rd/1st vs. cmv on the functionalized MNPs 
are much more significant than those on the unfunctionalized MNPs. With decreasing mimic 
virus concentration cmv, the R3rd/1st values of the unfunctionalized MNPs decrease as well, 
indicating that the non-specific binding or change in viscosity becomes less relevant at a low 
mimic virus concentration. The percentage of R3rd/1st for unfunctionalized MNPs to that for 
functionalized MNPs is less than 30%. In addition, it decreases to less than 20% with cmv = 
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0.84 nM. Additional control experiments on the MPS signal were also performed with BNF-
80 nanoparticles functionalized with some other antibodies (not specific to SARS-CoV-2 spike 
protein) and the mimic virus (data not shown), which also show minor changes in R3rd/1st. It 
means that the change in R3rd/1st is dominated by the specific binding between the antibody 
and antigen. Our experimental results demonstrate that the harmonic ratio R3rd/1st can be used 
for the detection of mimic SARS-CoV-2. 
 
Fig. 5. Absolute variation in measured harmonic ratio R3rd/1st vs. mimic SARS-CoV-2 concentration of 
functionalized (a) and unfunctionalized (b) MNPs at different excitation frequencies. Symbols are experimental 
results whereas solid lines are guides to the eyes. 
 
3.3 Limit of Detection 
The limit of detection (LOD) is one of the most important measures for sensitive detection. 
To evaluate the LOD, the measurement sensitivity  and noise level on the harmonic ratio are 
calculated. The measurement sensitivity, defined as the relative change in R3rd/1st to cmv 
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dR3rd/1st/dcmv, is calculated by a linear fitting of the R3rd/1st vs. cmv curves shown in Fig. 5. 
Figure 6a shows the measurement sensitivity vs. frequency curve for different excitation 
frequencies. It indicates that with increasing frequency from 140 to 1418 Hz the measurement 
sensitivity  decreases from 0.017 nM-1 to 0.004 nM-1, which quantitatively fits well with 
published results [16]. The noise level is calculated with the standard deviation  of 10-repeated 
measurements on the harmonic ratio of an MNP sample with cmv = 0 nM. In principle, with 
increasing the excitation frequency, the signal-to-noise ratio (SNR) of the measured harmonic 
gets improved, which would improve the standard deviation in measured harmonic ratio due 
to Faraday’s law. However, the data in frequencies of 299 Hz and 459 Hz show higher noise 
levels than that in 180 Hz, which may be caused by instabilities of the measurement system. 
Figure 6b shows the LOD , estimated from the measurement sensitivity  and standard 
deviation  by  = [30, 31]. It indicates that the LOD is in the range from about 0.10 to 
0.37 nM. Note that the estimated LOD is obtained for a single measurement. With n-time 
repeated measurements, the LOD can be further improved by a factor of √n. 
 
Fig. 6. (a) shows the measurement sensitivity of mimic SARS-CoV-2 (left axis) and standard deviation (right 
axis) vs. frequency curves. (b) shows the calculated limit of detection. 
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To experimentally investigate the LOD of mimic SARS-CoV-2 with the present approach, 
several samples with low mimic virus concentrations are prepared. Figure 7 shows the R3rd/1st 
vs. cmv curves measured at different frequencies. The experimental data were averaged from 4 
repeated measurements with a total measurement time of about 36 seconds (note that each of 
the 4 cycles includes 1 s measurement on the MNP sample, 7 s mechanical movement of the 
robot and 1 s background measurement). It clearly shows that for all the frequencies the lowest 
mimic virus concentration of about 0.084 nM is detectable, which is slightly better than the 
estimated LOD from 0.05 to 0.18 nM with 4 repeated measurements. It might be caused by the 
underestimation of the measurement sensitivity since the measurement sensitivity is not 
obtained at very low concentration of mimic virus. The present approach allows an LOD in 
terms of mimic virus concentration of about 0.084 nM with a sample volume of about 70 l 
and an LOD in terms of mole quantity of about 5.9 fmole. 
 
Fig. 7. Experimental results of R3rd/1st vs. mimic SARS-CoV-2 concentration at different frequencies. 
Experimental results are the average of 4-repeated measurements. Symbols are experimental data whereas solid 
lines are guides to the eye. 
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4. Discussion 
Rapid and highly sensitive detection of SARS-CoV-2 is of great importance to control the 
outbreak of SARS-CoV-2, thus improving the pandemic situation. This paper proposed the 
detection of SARS-CoV-2 with functionalized MNPs via the measurements of MPS signal, 
specifically the ratio of the 3rd to 1st harmonics. For a proof-of-concept, we used 100 nm-size 
polystyrene beads conjugated with SARS-CoV-2 spike protein to mimic SARS-CoV-2 while 
SARS-CoV-2 spike protein-functionalized MNPs are used as sensors. Our experimental results 
show that the present approach allows a highly sensitive detection of mimic SARS-CoV-2 with 
a LOD of about 0.084 nM (5.9 fmole) with 4-repeated measurements in about 36 seconds, 
including 4 seconds for measurement on an MNP sample, 28 seconds for mechanical 
movement and 4 seconds for background measurement. Note that the MPS system was built 
for two-dimensional imaging. With a tailored measurement system, we believe that the LOD 
can be further improved without any significant costs. For instance, a tailored MPS system can 
measure 36 averages of the MPS signal within a total measurement time of 36 s if a blank 
measurement is performed in advance. In this case, the LOD can be improved by a factor of 
√n with n repeated measurements.  
WHO has developed the ASSURED criteria as a benchmark to evaluate if tests address 
disease control needs: Affordable, Sensitive, Specific, User-friendly (simple to perform in a 
few steps with minimal training), Rapid and robust (results available in less than 30 min), 
Equipment-free and Deliverable to end-users [32, 33]. However, rare test methods can fit all 
the criteria in practice. MNP-based homogenous biosensing only requires the mixture of the 
functionalized MNPs and the sample to be test without any additional washing steps. The test 
results can be available in some seconds without taking into account the time required for 
antigen and antibody conjugation. Finally, the consuming time for the test results with the 
approach of MNP-based homogenous biosensing mainly depends on the kinetic of SARS-
CoV-2 antigen and antibody, which is in the order of about 10 min. It means that the present 
approach is sensitive, specific, and rapid and robust. The required materials – functionalized 
MNPs – are affordable, harmless and deliverable to end-users. Thus, it fits all the ASSURED 
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criteria except Equipment-free. However, the measurement setup – an MPS system, which 
consists of Helmholtz/solenoid coils for the generation of magnetic fields, pick-up coils for the 
detection of MNP magnetization, some basic electronics for power amplifiers, pre-amplifiers 
and analog-to-digital/digital-to-analog converters, can be built as a point-of-care (POC) device 
with a low cost. For ultra-sensitive detection of the analyte with the absolute signal from the 
magnetic response of functionalized MNPs, e.g. susceptibility and harmonic amplitude, the 
LOD may be dominated by the preparation error in the MNP concentration for measurements. 
The current approach employs the harmonic ratio of the 3rd to the 1st harmonics for bio-sensing, 
which is independent of MNP concentration but only dependent on the analyte concentration, 
thus eliminating the preparation error in the MNP concentration. Therefore, we believe that the 
present approach is one of the most promising approaches for rapid diagnostic of SARS-CoV-
2 in terms of the ASSURED criteria. 
For SARS-CoV-2 – this new virus, there have been still a lot of open questions to be 
investigated. For instance, it is still an open question that how many living viruses there are in 
a saliva sample and how the infectious possibility is for asymptomatic infection cases. Current 
approaches for RNA detection only give the information on the RNA concentration in a saliva 
sample. It means that they can only distinguish that some patients have been infected or not, 
but not the infection status. For instance, RNA-based test may not distinguish some infected 
patients with self-recovery who may just have some left virus RNA but no living viruses. An 
approach of living virus detection will give some further information on the quantity of living 
viruses in a saliva sample, which is of great importance for medical doctors to evaluate the 
infectiousness. We believe that the present approach allows highly sensitive, rapid and 
quantitative detection of living virus, which allows the evaluation of infection status. Especially, 
combination of RNA and living virus detection will significantly contribute to the 
understanding of the infection status and infectiousness. In addition, for the functionalized 
MNPs bound with 100 nm viruses, the change in the hydrodynamic size is much more 
significant than that for the functionalized MNPs bound with spike proteins. Thus, the direct 
detection of the virus, in principle, is more sensitive than that of the spike protein. Furthermore, 
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the current approach employs the measurement of magnetic signal of the functionalized MNPs, 
which does not have depth limitation. When combining with multi-color magnetic particle 
imaging [33-35], the present approach can be extended to visualize the spatial distribution of 
SARS-CoV-2 in vivo, which is of great significance and interest not only to control the 
outbreak of SARS-CoV-2 but also to fundamental researches, e.g. understanding the 
underlying mechanisms of the infection process and virus proliferation. 
5. Conclusion 
This paper investigated rapid and sensitive detection of SARS-CoV-2 with functionalized 
MNPs. For a proof-of-concept, functionalized MNPs were used as sensors to detect a mimic 
virus consisting of 100 nm-polystyrene beads conjugated with SARS-CoV-2 spike proteins. 
Experiments on ACS spectra and MPS signal of samples with different mimic virus 
concentrations were performed. Experimental results showed that the binding behavior 
between mimic SARS-CoV-2 and functionalized MNPs increases the effective Brownian 
relaxation time and changing the MPS signal. The change in the ratio of the 3rd to 1st harmonics 
with the mimic virus concentration was used to analyze the measurement sensitivity and limit 
of detection. We believe that the proposed approach is of great promise to highly sensitive and 
rapid detection with a low cost, easy handling of the sample to be detected (mix-and-measure). 
We envisage that the present work is of great interest and significance to develop new methods 
and design point-of-care devices for rapid diagnostics of SARS-CoV-2 to control its outbreak, 
as well as fundamental researches on the virus infection. 
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